Patent · US Expired

Human antibodies derived from immunized xenomice

US6713610B1 · kind B1 · utility

124Cited by
7References
14Claims
0Family size

Inventors

Key dates

Filing dateJul 11, 2000
Grant dateMar 30, 2004
Priority date
Expiry dateSep 1, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2840/203
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Fully human antibodies against a specific antigen can be prepared by administering the antigen to a transgenic animal which has been modified to produce such antibodies in response to antigenic challenge, but whose endogenous loci have been disabled. Various subsequent manipulations can be performed to obtain either antibodies per se or analogs thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.